Skip to content
LIVE MARKETS
--:--:--
ET
Testsite
Thoughts, stories and ideas.
40 filings/day — zero noise
Today's
stories · chronological wire
Search the wire
⌘K
Sign in
Subscribe
Home
TARS
TARS
1 story on the wire
TARS
1 filing
Chronological · ET
10:52
TARS
TARSUS Closes Alkeus Deal, Adding Phase 3 Stargardt Drug
Tarsus Pharmaceuticals has completed its acquisition of Alkeus, gaining worldwide rights to oral Stargardt disease candidate gildeuretinol.
M&A
Sep 4
8 days ago
PRO
No filings match.
Try another ticker or clear the filter.
LOAD EARLIER